neutralizing antibody response and efficacy of novel recombinant tetravalent dengue dna vaccine comprising envelope domain iii in mice

نویسندگان

ajit kulkarni department of virology, haffkine institute for traning, research and testing, acharya donde marg, mumbai-400012 india

rushil bhat department of virology, haffkine institute for traning, research and testing, acharya donde marg, mumbai-400012 india

mansi malik department of zoonosis, haffkine institute for traning, research and testing, acharya donde marg, mumbai-400012 india

suvarna sane national aids research institute, midc, bhosari, pune-411026 india

چکیده

background: dengue is a global arboviral threat to humans; causing 390 million infections per year. the availability of safe and effective tetravalent dengue vaccine is a global requirement to prevent epidemics, morbidity, and mortality associated with it. methods: five experimental groups (6 mice per group) each of 5-week-old balb/c mice were immunized with vaccine and placebo (empty plasmid) (100µg, i.m.) on days 0, 14 and 28. among these, four groups (one group per serotype) of each were subsequently challenged 3 weeks after the last boost with dengue virus (denv) serotypes 1-4 (100 ld 50 , 20 µl intracerebrally) to determine vaccine efficacy. the fifth group of each was used as a control. the pbs immunized group was used as mock control. serum samples were collected before and after subsequent immunizations. ediii fusion protein expression was determined by western blot. total protein concentration was measured by bradford assay. neutralizing antibodies were assessed by tcid 50 -cpe inhibition assay. statistical analysis was performed using stata/ic 10.1 software for windows. one-way repeated measures anova and mann-whitney test were used for neutralizing antibody analysis and vaccine efficacy, respectively. results: the recombinant ediii fusion protein was expressed adequately in transfected 293t cells. total protein concentration was almost 3 times more than the control. vaccine candidate induced neutralizing antibodies against all four denv serotypes with a notable increase after subsequent boosters. vaccine efficacy was 83.3% (denv-1, -3, -4) and 50% (denv-2). conclusion: our results suggest that vaccine is immunogenic and protective; however, further studies are required to improve the immunogenicity particularly against denv-2.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice

Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. The availability of safe and effective tetravalent dengue vaccine is a global requirement to prevent epidemics, morbidity, and mortality associated with it. Methods: Five experimental groups (6 mice per group) each of 5-week-old BALB/c mice were immunized with vaccine and placebo (empty plasmid) ...

متن کامل

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice

BACKGROUND Dengue is a global arboviral threat to humans; causing 390 million infections per year. The availability of safe and effective tetravalent dengue vaccine is a global requirement to prevent epidemics, morbidity, and mortality associated with it. METHODS Five experimental groups (6 mice per group) each of 5-week-old BALB/c mice were immunized with vaccine and placebo (empty plasmid) ...

متن کامل

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice

We developed a novel platform to express high levels of recombinant lipoproteins with intrinsic adjuvant properties. Based on this technology, our group developed recombinant lipidated dengue envelope protein domain IIIs as vaccine candidates against dengue virus. This work aims to evaluate the immune responses in mice to the tetravalent formulation. We demonstrate that 4 serotypes of recombina...

متن کامل

Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Truncated recombinant dengue virus envelope protein subunits (80E) are efficiently expressed using the Drosophila Schneider-2 (S2) cell expression system. Binding of conformationally sensitive antibodies as well as X-ray crystal structural studies indicate that the recombinant 80E subunits are properly folded native-like proteins. Combining the 80E subunits from each of the four dengue serotype...

متن کامل

Short report: Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine.

Recombinant proteins containing the B domain of dengue virus serotypes 1-4 fused to the maltose binding protein (MBP) of Escherichia coli were evaluated individually and as a tetravalent vaccine candidate in mice. Sera from mice immunized with monovalent DEN-MBP recombinant protein vaccines developed high titers of serotype homologous antibody in the enzyme-linked immunosorbent assay and the pl...

متن کامل

Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines

DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluated neutralizing antibody (NAb) induction of a dengue tetravalent DNA (TDNA) vaccine candidate administered by intramuscular-electroporation (IM-EP) and the benefit of homologous TDNA boosting in mice. Consensus humanized pre-membrane (prM) and envelope (E) of each serotypes, based on isolates fro...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of medical sciences

جلد ۴۲، شماره ۲، صفحات ۱۵۲-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023